Lv1
10 积分 2023-03-16 加入
Comparing ceftazidime/avibactam and polymyxin B for treating carbapenem-resistant organisms infections: a propensity score-matched retrospective cohort study
12小时前
待确认
Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa
14小时前
求助中
Clindamycin in the Treatment of Streptococcal and Staphylococcal Toxic Shock Syndromes
18天前
已完结
Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy
1个月前
已完结
Extensive‐stage small‐cell lung cancer: Current management and future directions
1个月前
已完结
Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options
1个月前
已完结
Will the Markov model and partitioned survival model lead to different results? A review of recent economic evidence of cancer treatments
1个月前
已完结
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study
2个月前
已完结
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
3个月前
已完结
Population pharmacokinetics and Monte Carlo simulations of sulbactam to optimize dosage regimens in patients with ventilator-associated pneumonia caused by Acinetobacter baumannii
3个月前
已完结
皖公网安备34019202002308
